Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer

por Vonderheide, Robert H., Bear, Adham S.
Publicado 2020

T Cells as Vehicles for Cancer Vaccination

por Bear, Adham S., Cruz, Conrad R., Foster, Aaron E.
Publicado 2011

T cells enhance gold nanoparticle delivery to tumors in vivo

por Kennedy, Laura C, Bear, Adham S, Young, Joseph K, Lewinski, Nastassja A, Kim, Jean, Foster, Aaron E, Drezek, Rebekah A
Publicado 2011

Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy

por Lin, Adam Yuh, Mattos Almeida, Joao Paulo, Bear, Adham, Liu, Nathan, Luo, Laureen, Foster, Aaron Edward, Drezek, Rebekah Anna
Publicado 2013

Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model

por Galvan, Daniel L., O’Neil, Richard T., Foster, Aaron E., Huye, Leslie, Bear, Adham, Rooney, Cliona M., Wilson, Matthew H.
Publicado 2015

High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro

por Lin, Adam Yuh, Lunsford, Jessica, Bear, Adham Sean, Young, Joseph Keith, Eckels, Phillip, Luo, Laureen, Foster, Aaron Edward, Drezek, Rebekah Anna
Publicado 2013

Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer

por Bear, Adham S., Kennedy, Laura C., Young, Joseph K., Perna, Serena K., Mattos Almeida, Joao Paulo, Lin, Adam Y., Eckels, Phillip C., Drezek, Rebekah A., Foster, Aaron E.
Publicado 2013

Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer

por Arscott, William T., Nead, Kevin T., Bear, Adham, Venigalla, Sriram, Shabason, Jacob, Lukens, John N., Plastaras, John P., Wojcieszynski, Andrzej, Metz, James, O’Hara, Mark, Reiss, Kim A., Teitelbaum, Ursina, Loaiza-Bonilla, Arturo, Drebin, Jeffrey, Lee, Major K., Shroff, Stuti G., Ben-Josef, Edgar
Publicado 2021

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

por Bear, Adham S., Blanchard, Tatiana, Cesare, Joseph, Ford, Michael J., Richman, Lee P., Xu, Chong, Baroja, Miren L., McCuaig, Sarah, Costeas, Christina, Gabunia, Khatuna, Scholler, John, Posey, Avery D., O’Hara, Mark H., Smole, Anze, Powell, Daniel J., Garcia, Benjamin A., Vonderheide, Robert H., Linette, Gerald P., Carreno, Beatriz M.
Publicado 2021